Plaque Volume Over Stenosis Degree

Paradigms are bound to eventually change. After years blinded by stenosis degree, plaque volume has proven to be a better predictor of cardiovascular events and death. Thus, patients with similar degrees of atherosclerosis burden have a similar prognosis, regardless of their lesions being obstructive or not.

El volumen de placa por sobre el grado de estenosis

The aim of this work was to assess whether obstructive disease has an additional predictive value beyond its association with the total number of calcified atherosclerotic lesions evaluated by tomography.

This analysis, recently published in JACC, included 23,759 symptomatic patients diagnosed by angiography. Major cardiovascular events (infarction, stroke, and all-cause mortality) were stratified by atherosclerotic burden and number of affected vessels.

After a median follow-up of 4.3 years, 1054 patients experienced their first cardiovascular event. The event rate increased with both higher calcium scores and higher number of affected vessels. With a calcium score of 0, the event rate was 6.2 patients per 1000, while a >1000 score indicated a risk of 42.3 patients per 1000.

Having 1 affected vessel provided a similar risk of events than a calcium score of 0 (6.1 patients per 1000), while having all 3 vessels affected was not as severe as a calcium score >1000 (34.7 patients per 1000).


Read also: Sapien 3 Performs Well in “Jobs” for Which It Is Not Designed.


After stratifying patients into 5 groups according to their calcium score (0, 1-99, 100-399, 400-1000, and >1000), the presence of obstructive disease was not associated with a higher risk when compared with patients without obstructive disease.

Conclusion

Plaque volume, and not stenosis per se, is the best predictor for cardiovascular events and death.

j-jacc-2020-10-021free

Original title: Impact of Plaque Burden Versus Stenosis on Ischemic Events in Patients With Coronary Atherosclerosis.

Reference: Martin Bødtker Mortensen et al. J Am Coll Cardiol 2020;76:2803–13 https://doi.org/10.1016/j.jacc.2020.10.021.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

High Ischaemic Risk Criteria in Chronic Coronary Syndrome: Prevalence and Prognosis

Despite advances in the management of chronic coronary syndrome (CCS), including the widespread use of drug-eluting stents (DES) and the optimization of medical therapy,...

ACC 2026 | DKCRUSH VIII: IVUS or angiography to guide PCI in complex coronary bifurcations

Intracoronary imaging guidance has become an established recommended strategy in complex coronary lesions. In the specific setting of complex bifurcations, uncertainty remained regarding the...

ACC 2026 | OPTIMAL: IVUS Guidance in PCI of the Unprotected Left Main Coronary Artery

Percutaneous coronary intervention (PCI) is considered an equivalent alternative to coronary artery bypass surgery in patients with left main coronary artery (LMCA) stenosis and...

ACC 2026 | IVUS-CHIP Trial: Intravascular ultrasound–guided versus angiography-guided complex PCI

Optimization of percutaneous coronary intervention (PCI) in complex lesions remains a relevant clinical challenge. In this context, the IVUS-CHIP trial was designed to evaluate...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

High Ischaemic Risk Criteria in Chronic Coronary Syndrome: Prevalence and Prognosis

Despite advances in the management of chronic coronary syndrome (CCS), including the widespread use of drug-eluting stents (DES) and the optimization of medical therapy,...

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...

Experience with the intra-annular self-expanding Navitor valve: data from the STS/ACC TVT registry

The expansion of TAVI, with the introduction of new-generation devices, has prioritized not only periprocedural safety, but also the preservation of coronary access, more...